Faculty profile

Madeleine Durand

ResearcherMédecine interneUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses may be missing. Find their university profile.

Madeleine Durand

Researcher

Médecine interne

Health Sciences

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
35 publications in the last five years, latest in 2026.
Senior (last) author on 4 recent papers, a sign of leading a research group.
Principal investigator on 10 research grants (10 CIHR), most recently in 2025.
Supervisor on 1 trainee award (1 CIHR), most recently in 2020.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

382

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Hiv Cardiovascular Aging Inflammation Comorbidity Gender Frailty Adaptive Trials

Latest papers

The Biobanque Québécoise de la COVID-19: Anticipate to Innovate.
Biopreservation and biobanking · 2026
Safety and effectiveness of direct oral anticoagulants in AF patients with nonmechanical valves.
Heart rhythm · 2026 · senior author
Nef and Vpu protect infected cells from ADCP mediated by plasma from people with HIV-1.
mBio · 2026

All 73 publications

Latest funding

Building Capacity in Innovative Adaptive Trial Designs for HIV and STBBI Research: The CTN-Québec Training Platform
CIHR · 2025 · Nominated PI
$800,000
The Sonographic Assessment of the Optic Nerve Sheath in Giant Cell Arteritis (SONIC-GCA)
CIHR · 2025 · Co-investigator
$569,926
FOREGROUNDING THE VOICES OF WOMEN TO BETTER MEET THEIR NEEDS: Applying multiple methods to enhance research engagement and clinical outcomes of women who use drugs
CIHR · 2024 · Co-investigator
$1,999,625

All 22 grants and awards

73 publications.

The Biobanque Québécoise de la COVID-19: Anticipate to Innovate.

Bhattacharjee M, Bérubé J, Durand M, Rousseau S, Zawati MH

Biopreservation and biobanking2026

DOI: 10.1177/19475535261429759 PMID: 41805007

Safety and effectiveness of direct oral anticoagulants in AF patients with nonmechanical valves.

Greiss I, Sinyavskaya L, Matteau A, Costi P, Coutu B, Mansour F, Raymond JM, Saint-Phard W, Durand M

Heart rhythm2026Senior author

DOI: 10.1016/j.hrthm.2025.06.047 PMID: 40602671

Nef and Vpu protect infected cells from ADCP mediated by plasma from people with HIV-1.

Bélanger É, Tauzin A, Tajebe F, Chandravanshi M, Yang D, Chen H-C, Chiu T-J, Bourassa C, Medjahed H, Tolbert WD, Durand M, Richard J, Huryn DM, Stäger S, Pazgier M, Finzi A

mBio2026

DOI: 10.1128/mbio.01487-26 PMID: 42523129

Determinants of cardiovascular and metabolic noncommunicable diseases among people living with HIV in Rwanda: protocol for the NCOHIRWA prospective cohort study.

Dushimiyimana V, Twagirumukiza M, Durand M, Ntusi NAB, Kateera BA, Bigirimana N, Nshimiyimana L, Ndishimye P, Umuhire VN, Karame P, Ndagijimana V, Mucumbitsi J, Dusabimana A, Ingabire C, Uwera YDN, Islam KMM, Hategeka C, Nsanzimana S, Rietzschel E, Callens S, NCOHIRWA Cohort Study Group

BMC infectious diseases2026

DOI: 10.1186/s12879-026-13776-8 PMID: 42288743

Prevalence, correlates of dyslipidaemia, and 10-year cardiovascular risk among people living with HIV and people without HIV adults in Rwanda: insights from the NCOHIRWA cohort study.

Dushimiyimana V, Kirunga YMI, Tuyishime A, Tuyishime S, Islam KMM, Nshimiyimana L, Niyonkuru VU, Gahamanyi N, Nsanzabaganwa C, Mukashema P, Kong J, Durand M, Ntusi NAB, Twagirumukiza M, Kateera BA, Nsanzimana S, Callens S, NCOHIRWA Cohort Study Group

Lipids in health and disease2025

DOI: 10.1186/s12944-025-02813-1 PMID: 41366776

Transcriptomic profiling of severe and critical COVID-19 patients reveals alterations in expression, splicing and polyadenylation.

Labrecque M, Brunet-Ratnasingham E, Hamilton LK, Auld D, Montpetit A, Richards B, Durand M, Rousseau S, Finzi A, Kaufmann DE, Tetreault M

Scientific reports2025

DOI: 10.1038/s41598-025-95905-y PMID: 40251257

Risk estimation in HIV reveals our usual blind spots.

Durand M

The lancet. HIV2025First author

DOI: 10.1016/s2352-3018(24)00351-5 PMID: 39832520

Opposite Roles of IL-32α Versus IL-32β/γ Isoforms in Promoting Monocyte-Derived Osteoblast/Osteoclast Differentiation and Vascular Calcification in People with HIV.

Ramani H, Cleret-Buhot A, Sylla M, Bunet R, Bertrand F, Peet MM, Chartrand-Lefebvre C, Trottier B, Thomas R, Routy JP, Fortin C, Martel-Laferrière V, Sadouni M, Cloutier G, Allard L, Kizer JR, Chomont N, Ancuta P, Hanna DB, Kaplan RC, Jenabian MA, Landay AL, Durand M, El-Far M, Tremblay CL

Cells2025

DOI: 10.3390/cells14070481 PMID: 40214435

CD4 T cell counts are inversely correlated with anti-gp120 cluster A antibodies in antiretroviral therapy-treated PLWH.

Benlarbi M, Richard J, Clemente T, Bourassa C, Tolbert WD, Gottumukkala S, Messier-Peet M, Medjahed H, Pazgier M, Maldarelli F, Castagna A, Durand M, Finzi A

EBioMedicine2025

DOI: 10.1016/j.ebiom.2025.105856 PMID: 40684476

Alterations in Circulating T-Cell Subsets with Gut-Homing/Residency Phenotypes Associated with HIV-1 Status and Subclinical Atherosclerosis.

Moreira Gabriel E, Dias J, Filali-Mouhim A, Caballero RE, Wiche Salinas TR, Nayrac M, Chartrand-Lefebvre C, Routy JP, Durand M, El-Far M, Tremblay C, Ancuta P

Cells2025

DOI: 10.3390/cells14211732 PMID: 41227377

Something wrong or missing on this profile? Suggest a correction

Madeleine Durand

Research

Latest papers

Latest funding

The Biobanque Qu&#xe9;b&#xe9;coise de la COVID-19: Anticipate to Innovate.

Safety and effectiveness of direct oral anticoagulants in AF patients with nonmechanical valves.

Nef and Vpu protect infected cells from ADCP mediated by plasma from people with HIV-1.

Determinants of cardiovascular and metabolic noncommunicable diseases among people living with HIV in Rwanda: protocol for the NCOHIRWA prospective cohort study.

Prevalence, correlates of dyslipidaemia, and 10-year cardiovascular risk among people living with HIV and people without HIV adults in Rwanda: insights from the NCOHIRWA cohort study.

Transcriptomic profiling of severe and critical COVID-19 patients reveals alterations in expression, splicing and polyadenylation.

Risk estimation in HIV reveals our usual blind spots.

Opposite Roles of IL-32&#x3b1; Versus IL-32&#x3b2;/&#x3b3; Isoforms in Promoting Monocyte-Derived Osteoblast/Osteoclast Differentiation and Vascular Calcification in People with HIV.

CD4 T cell counts are inversely correlated with anti-gp120 cluster A antibodies in antiretroviral therapy-treated PLWH.

Alterations in Circulating T-Cell Subsets with Gut-Homing/Residency Phenotypes Associated with HIV-1 Status and Subclinical Atherosclerosis.

Frequent collaborators

Madeleine Durand

Carl Chartrand-Lefebvre

Jean-Pierre Routy

Christel Renoux

Nicolas Chomont

Jean-Pierre Routy

Nicolas Chomont

Mohammad-Ali Jenabian

Mohammad-Ali Jenabian

Mohammad-Ali Jenabian

Petronela Ancuta

Samer Mansour

Gilles Soulez

Gilles Soulez

Gilles Soulez

J Michael Paterson

Daniel von Renteln

Sirui Zhou

Laurent Azoulay

Daniel von Renteln

Christos Tsoukas

Erwin Schurr

Laurent Azoulay

Anne Marie Holbrook

Jean-Eric Tarride

Guy Cloutier

Simon Rousseau

Marina Klein

Mona Loutfy

Neora Pick

Philip Devereaux

Jonathan Afilalo

Jessica Spence

Ameen Patel

John Harlock

David Conen

The Biobanque Québécoise de la COVID-19: Anticipate to Innovate.

Opposite Roles of IL-32α Versus IL-32β/γ Isoforms in Promoting Monocyte-Derived Osteoblast/Osteoclast Differentiation and Vascular Calcification in People with HIV.